{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-011630","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.429208+00:00","generated_at":"2026-05-16T00:26:32.762725+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"agilon health Q4 net loss $189M, revenue $1.57B; 2026 guidance Adj EBITDA breakeven","bullets":["Q4 net loss $189M vs $106M loss YoY; FY net loss $391M vs $260M loss.","Medical margin Q4 negative $74M vs positive $1M YoY; FY negative $57M vs positive $205M.","Adjusted EBITDA Q4 loss $142M vs $84M; FY loss $296M vs $154M.","Membership 625k (-5% YoY) from market exits; MA members 511k, ACO 114k.","2026 guidance: revenue $5.41-5.58B, Adj EBITDA ($15M)-$15M midpoint breakeven."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-011630","json":"https://secwatch.observer/filing/0001628280-26-011630.json","markdown":"https://secwatch.observer/filing/0001628280-26-011630.md","text":"https://secwatch.observer/filing/0001628280-26-011630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828026011630/0001628280-26-011630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828026011630/agl-20260225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:26:32.762725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}